Company CVAbout Unjha Formulations Ltd 
Unjha Formulations Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
Company Coordinates
Company Details
Khali Char Rasta, State Highway Ta Sidhpur Patan Gujarat : 384151
Registrar Details
Link Intime India Pvt Ltd., UnitNo. 303, 3rd Floor, Shoppers Plaza V, Opp. Municipal Market, B/h. Shoppers Plaza II, Off. C. G. Road,, Ahmedabad
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Jashodaben Shambhubhai Patel (16.51%)
Highest Public shareholder
Esha Mayank Patel (1.6%)
Individual Investors Holdings
56.19%
Board of Directors
Management
Designation
Remuneration
Krutiben M Patel
Managing Director
5.2 lacs
Hasmukh C Chavda
Independent Director
0
Jashodaben S Patel
Chairman (Non-Executive)
0
Jitendrakumar Parshottamdas Limbachiya
Independent Director
0
Jigar Ray
Company Sec. & Compli. Officer
0
Mustufa Najmuddin
Independent Director
0
Esham. Patel
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
7.85743
0%
Raw Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Powder
11.26
98.62%
Tablets
0.16
1.38%
Powder
Powder
Tablets
Tablets
Stock DNARevenue and Profits:
Net Sales:
4 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
Pharmaceuticals & Biotechnology
INR 11 Cr (Micro Cap)
11.00
34
0.00%
-0.20
32.48%
3.60
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
